Louise Johnson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Chemicals & Drugs

Phenomena

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Johnson Louise N
The regulation of protein phosphorylation.
Johnson Louise N
Protein kinase inhibitors: contributions from structure to clinical compounds.
Vénien-Bryan Catherine; Jonic Slavica; Skamnaki Vasiliki; Brown Nick; Bischler Nicolas; Oikonomakos Nikos G; Boisset Nicolas; Johnson Louise N
The structure of phosphorylase kinase holoenzyme at 9.9 angstroms resolution and location of the catalytic subunit and the substrate glycogen phosphorylase.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Louise Johnson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Johnson Louise N
The regulation of protein phosphorylation.
Biochemical Society transactions 2009;37(Pt 4):627-41.
2009: Johnson Louise N
Protein kinase inhibitors: contributions from structure to clinical compounds.
Quarterly reviews of biophysics 2009;42(1):1-40.
2009: Vénien-Bryan Catherine; Jonic Slavica; Skamnaki Vasiliki; Brown Nick; Bischler Nicolas; Oikonomakos Nikos G; Boisset Nicolas; Johnson Louise N
The structure of phosphorylase kinase holoenzyme at 9.9 angstroms resolution and location of the catalytic subunit and the substrate glycogen phosphorylase.
Structure (London, England : 1993) 2009;17(1):117-27.
2009: Davies Karen M; Lowe Ed D; Vénien-Bryan Catherine; Johnson Louise N
The HupR receiver domain crystal structure in its nonphospho and inhibitory phospho states.
Journal of molecular biology 2009;385(1):51-64.
2008: Lowe Edward D; Gao Guang-Yao; Johnson Louise N; Keung Wing Ming
Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase.
Journal of medicinal chemistry 2008;51(15):4482-7.
2008: Johnson Louise N
Early days of structural biology.
Cellular and molecular life sciences : CMLS 2008;65(15):2271-6.
2008: Baumli Sonja; Lolli Graziano; Lowe Edward D; Troiani Sonia; Rusconi Luisa; Bullock Alex N; Debreczeni Judit E; Knapp Stefan; Johnson Louise N
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
The EMBO journal 2008;27(13):1907-18.
2008: Johnson Tim M; Antrobus Robin; Johnson Louise N
Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP).
Biochemistry 2008;47(12):3688-96.
2007: Brown Nick R; Lowe Ed D; Petri Ed; Skamnaki Vicky; Antrobus Robin; Johnson Louise N
Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
Cell cycle (Georgetown, Tex.) 2007;6(11):1350-9.
2007: Lolli Graziano; Johnson Louise N
Recognition of Cdk2 by Cdk7.
Proteins 2007;67(4):1048-59.
2006: Cheng Kin-Yip; Noble Martin E M; Skamnaki Vicky; Brown Nick R; Lowe Ed D; Kontogiannis Luke; Shen Kui; Cole Philip A; Siligardi Giuliano; Johnson Louise N
The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition.
The Journal of biological chemistry 2006;281(32):23167-79.
2006: Davies Karen M; Skamnaki Vasiliki; Johnson Louise N; Vénien-Bryan Catherine
Structural and functional studies of the response regulator HupR.
Journal of molecular biology 2006;359(2):276-88.
2006: Geremia Silvano; Campagnolo Mara; Demitri Nicola; Johnson Louise N
Simulation of diffusion time of small molecules in protein crystals.
Structure (London, England : 1993) 2006;14(3):393-400.
2006: Lowe Edward D; Hasan Na'il; Trempe Jean Francois; Fonso Laura; Noble Martin E M; Endicott Jane A; Johnson Louise N; Brown Nick R
Structures of the Dsk2 UBL and UBA domains and their complex.
Acta crystallographica. Section D, Biological crystallography 2006;62(Pt 2):177-88.
2005: Passmore Lori A; Booth Christopher R; Vénien-Bryan Catherine; Ludtke Steven J; Fioretto Céline; Johnson Louise N; Chiu Wah; Barford David
Structural analysis of the anaphase-promoting complex reveals multiple active sites and insights into polyubiquitylation.
Molecular cell 2005;20(6):855-66.
2005: Kuo Anling; Domene Carmen; Johnson Louise N; Doyle Declan A; Vénien-Bryan Catherine
Two different conformational states of the KirBac3.1 potassium channel revealed by electron crystallography.
Structure (London, England : 1993) 2005;13(10):1463-72.
2005: Lolli Graziano; Johnson Louise N
CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?
Cell cycle (Georgetown, Tex.) 2005;4(4):572-7.
2005: Cook Atlanta G; Johnson Louise N; McDonnell James M
Structural characterization of Ca2+/CaM in complex with the phosphorylase kinase PhK5 peptide.
The FEBS journal 2005;272(6):1511-22.
2005: Honda Reiko; Lowe Edward D; Dubinina Elena; Skamnaki Vicky; Cook Atlanta; Brown Nick R; Johnson Louise N
The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles.
The EMBO journal 2005;24(3):452-63.
2004: Lolli Graziano; Lowe Edward D; Brown Nick R; Johnson Louise N
The crystal structure of human CDK7 and its protein recognition properties.
Structure (London, England : 1993) 2004;12(11):2067-79.
2004: Noble Martin E M; Endicott Jane A; Johnson Louise N
Protein kinase inhibitors: insights into drug design from structure.
Science (New York, N.Y.) 2004;303(5665):1800-5.
2003: Cheng Kin-Yip; Lowe Edward D; Sinclair John; Nigg Erich A; Johnson Louise N
The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.
The EMBO journal 2003;22(21):5757-68.
2003: De Moliner Erika; Brown Nick R; Johnson Louise N
Alternative binding modes of an inhibitor to two different kinases.
European journal of biochemistry / FEBS 2003;270(15):3174-81.
2003: Mesguiche Veronique; Parsons Rachel J; Arris Christine E; Bentley Johanne; Boyle F Thomas; Curtin Nicola J; Davies Thomas G; Endicott Jane A; Gibson Ashleigh E; Golding Bernard T; Griffin Roger J; Jewsbury Philip; Johnson Louise N; Newell David R; Noble Martin E M; Wang Lan Z; Hardcastle Ian R
4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2.
Bioorganic & medicinal chemistry letters 2003;13(2):217-22.
2002: Lowe Edward D; Tews Ivo; Cheng Kin Yip; Brown Nick R; Gul Sheraz; Noble Martin E M; Gamblin Steven J; Johnson Louise N
Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
Biochemistry 2002;41(52):15625-34.
2002: Davies Thomas G; Bentley Johanne; Arris Christine E; Boyle F Thomas; Curtin Nicola J; Endicott Jane A; Gibson Ashleigh E; Golding Bernard T; Griffin Roger J; Hardcastle Ian R; Jewsbury Philip; Johnson Louise N; Mesguiche Veronique; Newell David R; Noble Martin E M; Tucker Julie A; Wang Lan; Whitfield Hayley J
Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor.
Nature structural biology 2002;9(10):745-9.
2002: Geremia S; Campagnolo M; Schinzel R; Johnson L N
Enzymatic catalysis in crystals of Escherichia coli maltodextrin phosphorylase.
Journal of molecular biology 2002;322(2):413-23.
2002: Gibson Ashleigh E; Arris Christine E; Bentley Johanne; Boyle F Thomas; Curtin Nicola J; Davies Thomas G; Endicott Jane A; Golding Bernard T; Grant Sharon; Griffin Roger J; Jewsbury Philip; Johnson Louise N; Mesguiche Veronique; Newell David R; Noble Martin E M; Tucker Julie A; Whitfield Hayley J
Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives.
Journal of medicinal chemistry 2002;45(16):3381-93.
2002: Cook A; Lowe E D; Chrysina E D; Skamnaki V T; Oikonomakos N G; Johnson L N
Structural studies on phospho-CDK2/cyclin A bound to nitrate, a transition state analogue: implications for the protein kinase mechanism.
Biochemistry 2002;41(23):7301-11.
2002: Davies Thomas G; Pratt David J; Endicott Jane A; Johnson Louise N; Noble Martin E M
Structure-based design of cyclin-dependent kinase inhibitors.
Pharmacology & therapeutics 2002;93(2-3):125-33.
2002: Johnson Louise N; De Moliner Erika; Brown Nick R; Song Haiwei; Barford David; Endicott Jane A; Noble Martin E M
Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.
Pharmacology & therapeutics 2002;93(2-3):113-24.
2002: Vénien-Bryan Catherine; Lowe Edward M; Boisset Nicolas; Traxler Kenneth W; Johnson Louise N; Carlson Gerald M
Three-dimensional structure of phosphorylase kinase at 22 A resolution and its complex with glycogen phosphorylase b.
Structure (London, England : 1993) 2002;10(1):33-41.
2002: van Thor Jasper J; Gensch Thomas; Hellingwerf Klaas J; Johnson Louise N
Phototransformation of green fluorescent protein with UV and visible light leads to decarboxylation of glutamate 222.
Nature structural biology 2002;9(1):37-41.
2001: Lawrie A M; Tito P; Hernandez H; Brown N R; Robinson C V; Endicott J A; Noble M E; Johnson L N
Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells.
Protein expression and purification 2001;23(2):252-60.
2001: Song H; Hanlon N; Brown N R; Noble M E; Johnson L N; Barford D
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
Molecular cell 2001;7(3):615-26.
2001: Johnson L N
Structural basis for substrate recognition and control in protein kinases.
Ernst Schering Research Foundation workshop 2001;(34):47-69.
2000: Oikonomakos N G; Schnier J B; Zographos S E; Skamnaki V T; Tsitsanou K E; Johnson L N
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.
The Journal of biological chemistry 2000;275(44):34566-73.
2000: Ghosh M; Meerts I A; Cook A; Bergman A; Brouwer A; Johnson L N
Structure of human transthyretin complexed with bromophenols: a new mode of binding.
Acta crystallographica. Section D, Biological crystallography 2000;56(Pt 9):1085-95.
2000: Arris C E; Boyle F T; Calvert A H; Curtin N J; Endicott J A; Garman E F; Gibson A E; Golding B T; Grant S; Griffin R J; Jewsbury P; Johnson L N; Lawrie A M; Newell D R; Noble M E; Sausville E A; Schultz R; Yu W
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles.
Journal of medicinal chemistry 2000;43(15):2797-804.
2000: Oikonomakos N G; Skamnaki V T; Tsitsanou K E; Gavalas N G; Johnson L N
A new allosteric site in glycogen phosphorylase b as a target for drug interactions.
Structure (London, England : 1993) 2000;8(6):575-84.
1999: Brown N R; Noble M E; Endicott J A; Johnson L N
The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
Nature cell biology 1999;1(7):438-43.
1999: Skamnaki V T; Owen D J; Noble M E; Lowe E D; Lowe G; Oikonomakos N G; Johnson L N
Catalytic mechanism of phosphorylase kinase probed by mutational studies.
Biochemistry 1999;38(44):14718-30.
1999: Watson K A; McCleverty C; Geremia S; Cottaz S; Driguez H; Johnson L N
Phosphorylase recognition and phosphorolysis of its oligosaccharide substrate: answers to a long outstanding question.
The EMBO journal 1999;18(17):4619-32.
1999: Johnson L N; Petsko G A
David Phillips and the origin of structural enzymology.
Trends in biochemical sciences 1999;24(7):287-9.
1999: O'Reilly M; Watson K A; Johnson L N
The crystal structure of the Escherichia coli maltodextrin phosphorylase-acarbose complex.
Biochemistry 1999;38(17):5337-45.
1999: Tsitsanou K E; Oikonomakos N G; Zographos S E; Skamnaki V T; Gregoriou M; Watson K A; Johnson L N; Fleet G W
Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure.
Protein science : a publication of the Protein Society 1999;8(4):741-9.
1999: Brown N R; Noble M E; Lawrie A M; Morris M C; Tunnah P; Divita G; Johnson L N; Endicott J A
Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
The Journal of biological chemistry 1999;274(13):8746-56.
1998: Johnson L N
The early history of lysozyme.
Nature structural biology 1998;5(11):942-4.
1998: Johnson L N; Lowe E D; Noble M E; Owen D J
The Eleventh Datta Lecture. The structural basis for substrate recognition and control by protein kinases.
FEBS letters 1998;430(1-2):1-11.
1998: Gregoriou M; Noble M E; Watson K A; Garman E F; Krulle T M; de la Fuente C; Fleet G W; Oikonomakos N G; Johnson L N
The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding.
Protein science : a publication of the Protein Society 1998;7(4):915-27.
1997: Noble M E; Endicott J A; Brown N R; Johnson L N
The cyclin box fold: protein recognition in cell-cycle and transcription control.
Trends in biochemical sciences 1997;22(12):482-7.
1997: Zographos S E; Oikonomakos N G; Tsitsanou K E; Leonidas D D; Chrysina E D; Skamnaki V T; Bischoff H; Goldmann S; Watson K A; Johnson L N
The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor.
Structure (London, England : 1993) 1997;5(11):1413-25.
1997: Lowe E D; Noble M E; Skamnaki V T; Oikonomakos N G; Owen D J; Johnson L N
The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition.
The EMBO journal 1997;16(22):6646-58.
1997: Lawrie A M; Noble M E; Tunnah P; Brown N R; Johnson L N; Endicott J A
Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2.
Nature structural biology 1997;4(10):796-801.
1997: O'Reilly M; Watson K A; Schinzel R; Palm D; Johnson L N
Oligosaccharide substrate binding in Escherichia coli maltodextrin phosphorylase.
Nature structural biology 1997;4(5):405-12.
1997: Watson K A; Schinzel R; Palm D; Johnson L N
The crystal structure of Escherichia coli maltodextrin phosphorylase provides an explanation for the activity without control in this basic archetype of a phosphorylase.
The EMBO journal 1997;16(1):1-14.
1997: Johnson L N; Barford D; Owen D J; Noble M E; Garman E F
From phosphorylase to phosphorylase kinase.
Advances in second messenger and phosphoprotein research 1997;31():11-28.
1996: Johnson L N; O'Reilly M
Control by phosphorylation.
Current opinion in structural biology 1996;6(6):762-9.
1996: Oikonomakos N G; Zographos S E; Tsitsanou K E; Johnson L N; Acharya K R
Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.
Protein science : a publication of the Protein Society 1996;5(12):2416-28.
1996: Mitchell E P; Withers S G; Ermert P; Vasella A T; Garman E F; Oikonomakos N G; Johnson L N
Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
Biochemistry 1996;35(23):7341-55.
1996: Johnson L N; Noble M E; Owen D J
Active and inactive protein kinases: structural basis for regulation.
Cell 1996;85(2):149-58.
1995: Oikonomakos N G; Kontou M; Zographos S E; Watson K A; Johnson L N; Bichard C J; Fleet G W; Acharya K R
N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.
Protein science : a publication of the Protein Society 1995;4(12):2469-77.
1995: Oikonomakos N G; Zographos S E; Johnson L N; Papageorgiou A C; Acharya K R
The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies.
Journal of molecular biology 1995;254(5):900-17.
1995: Brown N R; Noble M E; Endicott J A; Garman E F; Wakatsuki S; Mitchell E; Rasmussen B; Hunt T; Johnson L N
The crystal structure of cyclin A.
Structure (London, England : 1993) 1995;3(11):1235-47.
1995: Board M; Bollen M; Stalmans W; Kim Y; Fleet G W; Johnson L N
Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes.
The Biochemical journal 1995;311 ( Pt 3)():845-52.
1995: Zographos S E; Oikonomakos N G; Dixon H B; Griffin W G; Johnson L N; Leonidas D D
Sulphate-activated phosphorylase b: the pH-dependence of catalytic activity.
The Biochemical journal 1995;310 ( Pt 2)():565-70.
1995: Watson K A; Mitchell E P; Johnson L N; Cruciani G; Son J C; Bichard C J; Fleet G W; Oikonomakos N G; Kontou M; Zographos S E
Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
Acta crystallographica. Section D, Biological crystallography 1995;51(Pt 4):458-72.
1995: Owen D J; Noble M E; Garman E F; Papageorgiou A C; Johnson L N
Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product.
Structure (London, England : 1993) 1995;3(5):467-82.
1995: Endicott J A; Noble M E; Garman E F; Brown N; Rasmussen B; Nurse P; Johnson L N
The crystal structure of p13suc1, a p34cdc2-interacting cell cycle control protein.
The EMBO journal 1995;14(5):1004-14.
1995: Board M; Hadwen M; Johnson L N
Effects of novel analogues of D-glucose on glycogen phosphorylase activities in crude extracts of liver and skeletal muscle.
European journal of biochemistry / FEBS 1995;228(3):753-61.
1995: Owen D J; Papageorgiou A C; Garman E F; Noble M E; Johnson L N
Expression, purification and crystallisation of phosphorylase kinase catalytic domain.
Journal of molecular biology 1995;246(3):374-81.
1994: Hadfield A T; Harvey D J; Archer D B; MacKenzie D A; Jeenes D J; Radford S E; Lowe G; Dobson C M; Johnson L N
Crystal structure of the mutant D52S hen egg white lysozyme with an oligosaccharide product.
Journal of molecular biology 1994;243(5):856-72.
1994: Johnson L N; Barford D
Electrostatic effects in the control of glycogen phosphorylase by phosphorylation.
Protein science : a publication of the Protein Society 1994;3(10):1726-30.
1994: Johnson L N
Professor Dorothy Hodgkin, OM, FRS. 1910-1994.
Nature structural biology 1994;1(9):573-6.
1994: Duke E M; Wakatsuki S; Hadfield A; Johnson L N
Laue and monochromatic diffraction studies on catalysis in phosphorylase b crystals.
Protein science : a publication of the Protein Society 1994;3(8):1178-96.
1994: Oikonomakos N G; Kontou M; Zographos S E; Tsitoura H S; Johnson L N; Watson K A; Mitchell E P; Fleet G W; Son J C; Bichard C J
The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase.
European journal of drug metabolism and pharmacokinetics 1994;19(3):185-92.
1994: Watson K A; Mitchell E P; Johnson L N; Son J C; Bichard C J; Orchard M G; Fleet G W; Oikonomakos N G; Leonidas D D; Kontou M
Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds.
Biochemistry 1994;33(19):5745-58.
1994: Noble M E; Cleasby A; Johnson L N; Egmond M R; Frenken L G
Analysis of the structure of Pseudomonas glumae lipase.
Protein engineering 1994;7(4):559-62.
1994: Endicott J A; Nurse P; Johnson L N
Mutational analysis supports a structural model for the cell cycle protein kinase p34.
Protein engineering 1994;7(2):243-53.
1993: Noble M E; Cleasby A; Johnson L N; Egmond M R; Frenken L G
The crystal structure of triacylglycerol lipase from Pseudomonas glumae reveals a partially redundant catalytic aspartate.
FEBS letters 1993;331(1-2):123-8.
1993: Johnson L N; Snape P; Martin J L; Acharya K R; Barford D; Oikonomakos N G
Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.
Journal of molecular biology 1993;232(1):253-67.
1993: Taguchi J E; Heyes S J; Barford D; Johnson L N; Dobson C M
Solid state 31P cross-polarization/magic angle sample spinning nuclear magnetic resonance of crystalline glycogen phosphorylase b.
Biophysical journal 1993;64(2):492-501.
1993: Johnson L N; Barford D
The effects of phosphorylation on the structure and function of proteins.
Annual review of biophysics and biomolecular structure 1993;22():199-232.
1992: Cox S; Johnson L N
Expression of the phosphorylase kinase gamma subunit catalytic domain in Escherichia coli.
Protein engineering 1992;5(8):811-9.
1992: Johnson L N
Time-resolved protein crystallography.
Protein science : a publication of the Protein Society 1992;1(10):1237-43.
1992: Leonidas D D; Oikonomakos N G; Papageorgiou A C; Acharya K R; Barford D; Johnson L N
Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.
Protein science : a publication of the Protein Society 1992;1(9):1112-22.
1992: Barford D; Johnson L N
The molecular mechanism for the tetrameric association of glycogen phosphorylase promoted by protein phosphorylation.
Protein science : a publication of the Protein Society 1992;1(4):472-93.
1992: Johnson L N
Glycogen phosphorylase: control by phosphorylation and allosteric effectors.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1992;6(6):2274-82.
1992: Johnson L N; Hu S H; Barford D
Catalytic mechanism of glycogen phosphorylase.
Faraday discussions 1992;(93):131-42.
1991: Martin J L; Veluraja K; Ross K; Johnson L N; Fleet G W; Ramsden N G; Bruce I; Orchard M G; Oikonomakos N G; Papageorgiou A C
Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes.
Biochemistry 1991;30(42):10101-16.
1991: Barford D; Hu S H; Johnson L N
Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.
Journal of molecular biology 1991;218(1):233-60.
1991: Duke E M; Hadfield A; Martin J L; Clifton I J; Hajdu J; Johnson L N; Reid G P; Trentham D R; Bruce I; Fleet G W
Towards time-resolved diffraction studies with glycogen phosphorylase.
Ciba Foundation symposium 1991;161():75-86; discussion 86-90.
1990: Martin J L; Johnson L N; Withers S G
Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b.
Biochemistry 1990;29(48):10745-57.
1990: Hajdu J; Johnson L N
Progress with Laue diffraction studies on protein and virus crystals.
Biochemistry 1990;29(7):1669-78.
1990: Johnson L N; Barford D
Glycogen phosphorylase. The structural basis of the allosteric response and comparison with other allosteric proteins.
The Journal of biological chemistry 1990;265(5):2409-12.
1990: Johnson L N; Acharya K R; Jordan M D; McLaughlin P J
Refined crystal structure of the phosphorylase-heptulose 2-phosphate-oligosaccharide-AMP complex.
Journal of molecular biology 1990;211(3):645-61.
1989: Barford D; Johnson L N
The allosteric transition of glycogen phosphorylase.
Nature 1989;340(6235):609-16.
1989: Oikonomakos N G; Acharya K R; Melpidou A E; Stuart D I; Johnson L N
The binding of beta-glycerophosphate to glycogen phosphorylase b in the crystal.
Archives of biochemistry and biophysics 1989;270(1):62-8.
1988: Sprang S R; Acharya K R; Goldsmith E J; Stuart D I; Varvill K; Fletterick R J; Madsen N B; Johnson L N
Structural changes in glycogen phosphorylase induced by phosphorylation.
Nature 1988;336(6196):215-21.
1988: Barford D; Schwabe J W; Oikonomakos N G; Acharya K R; Hajdu J; Papageorgiou A C; Martin J L; Knott J C; Vasella A; Johnson L N
Channels at the catalytic site of glycogen phosphorylase b: binding and kinetic studies with the beta-glycosidase inhibitor D-gluconohydroximo-1,5-lactone N-phenylurethane.
Biochemistry 1988;27(18):6733-41.
1988: Oikonomakos N G; Acharya K R; Stuart D I; Melpidou A E; McLaughlin P J; Johnson L N
Uridine(5')diphospho(1)-alpha-D-glucose. A binding study to glycogen phosphorylase b in the crystal.
European journal of biochemistry / FEBS 1988;173(3):569-78.
1987: Oikonomakos N G; Johnson L N; Acharya K R; Stuart D I; Barford D; Hajdu J; Varvill K M; Melpidou A E; Papageorgiou T; Graves D J
Pyridoxal phosphate site in glycogen phosphorylase b: structure in native enzyme and in three derivatives with modified cofactors.
Biochemistry 1987;26(25):8381-9.
1987: Johnson L N; Acharya K R; Stuart D I; Barford D; Oikonomakos N G; Hajdu J; Varvill K M
Phosphate-recognition sites in catalysis and control of glycogen phosphorylase b.
Biochemical Society transactions 1987;15(5):1001-5.
1987: Hajdu J; Machin P A; Campbell J W; Greenhough T J; Clifton I J; Zurek S; Gover S; Johnson L N; Elder M
Millisecond X-ray diffraction and the first electron density map from Laue photographs of a protein crystal.
Nature 1987;329(6135):178-81.
1985: Oikonomakos N G; Melpidou A E; Johnson L N
Crystallization of pig skeletal phosphorylase b. Purification, physical and catalytic characterization.
Biochimica et biophysica acta 1985;832(3):248-56.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Louise Johnson

Research Profile (preview)

Concepts & Ideas

Chemicals & Drugs

Procedures

Genes & Molecular Sequences

Living Beings

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Louise Johnson (preview)

All Publications